About Heartflow, Inc. (HTFL)
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
HTFL Key Statistics
| Current Price | $22.98 | Market Cap | $1.9 billion |
|---|---|---|---|
| Daily Change | -7.56% | Volume | 389K |
| 52-Week High | $41.22 | 52-Week Low | $20.13 |
| Sector | Healthcare | Industry | Health Information Services |
HTFL Price Performance
Heartflow, Inc. stock has returned -8.81% over the past day, -2.12% over the past week, +9.73% over the past month, and -35.19% over the past three months. The stock trades between a 52-week low of $20.13 and a high of $41.22.
HTFL Financial Fundamentals
Heartflow, Inc. reports, operating margin of -4507.00%, profit margin of -7472.00%, and revenue growth of +40.50%. The debt-to-equity ratio is 0.09. Current ratio stands at 8.60.